基于网络药理学和分子对接技术探讨虎杖治疗骨质疏松症的作用机制
Exploring the Efficacy of Polygonum cuspidatum in the Treatment of Osteoporosis Based on Network Pharmacology and Molecular Docking Technology
DOI: 10.12677/acm.2025.1592629, PDF,   
作者: 田志明:黑龙江中医药大学研究生院,黑龙江 哈尔滨;杨福彪*:黑龙江中医药大学附属第三医院,黑龙江 哈尔滨
关键词: 骨质疏松症虎杖网络药理学分子对接Osteoporosis Polygonum cuspidatum Network Pharmacology Molecular Docking
摘要: 目的:利用网络药理学和分子对接技术,探究虎杖治疗骨质疏松症的潜在靶点及分子机制。方法:通过TCMSP获取虎杖的有效成分和潜在靶点,并利用GeneCards以及OMIM数据库检索骨质疏松症的疾病靶点。使用Venny 2.1绘制韦恩图,获得交集靶点。利用Cytoscape 3.10软件,构建“虎杖–成分–靶点–疾病”网络图。将靶点信息导入STRING数据库,构建蛋白质相互作用(PPI)网络。在DAVID数据库中进行GO和KEGG分析。使用AutoDock软件,进行分子对接。结果:筛选出虎杖活性成分10种及潜在靶点204个,骨质疏松症对应的疾病靶点7792个,虎杖和骨质疏松症的交集靶点190个。虎杖治疗骨质疏松症的核心成分是槲皮素、木犀草素、β-谷甾醇等,IL-6、AKT1、IL-1β等为主要核心靶点。KEGG富集主要包括癌症通路、IL-17信号通路、TNF信号通路等。分子对接表明,虎杖主要活性组分与其核心靶标存在良好的结合力。结论:虎杖中有效成分可能通过IL-6、AKT1、IL-1β等重要靶点和信号通路,达到治疗骨质疏松症的作用。
Abstract: Objective: To study the potent targets and molecules of Polygonum cuspidatum in preventing osteoporosis, we used network pharmacology and molecular docking. Methods: The active compound and potential target data of Polygonum cuspidatum were collected from the TCMSP database. Concurrently, disease targets associated with osteoporosis were retrieved from the GeneCards and OMIM databases. Venny 2.1 Software was utilized to create a Venn diagram to identify the common targets between drugs and disease targets. Then, Cytoscape 3.10 was employed to construct a “drug-active ingredient-target-disease” network, and the STRING database was used to build a protein-protein interaction (PPI) network. Functional enrichment analysis, which included GO and KEGG analysis, was carried out using the DAVID database. Finally, molecular docking was used with AutoDock software to verify the binding affinities between key ingredients and targets. Results: Ten active compounds and 204 potential drug targets were selected from Polygonum cuspidatum, while 7792 disease targets related to osteoporosis were also identified, with 190 intersection targets identified. The core active components of Polygonum cuspidatum for treating osteoporosis include quercetin, rutin, and β-sitosterol, with primary target proteins including interleukin-6 (IL-6), protein kinase Bα (AKT1), and interleukin-1β (IL-1β), as the primary core targets. KEGG enrichment analyses primarily included cancer pathways, IL-17 signaling pathways, and TNF signaling pathways. Molecular docking results indicate that the active components of Polygonum cuspidatum have good binding affinity with its core targets. Conclusion: The active components in Polygonum cuspidatum may exert their therapeutic effects on osteoporosis through key targets and signaling pathways such as IL-6, AKT1, and IL-1β.
文章引用:田志明, 杨福彪. 基于网络药理学和分子对接技术探讨虎杖治疗骨质疏松症的作用机制[J]. 临床医学进展, 2025, 15(9): 1339-1349. https://doi.org/10.12677/acm.2025.1592629

参考文献

[1] Wang, Y., Chang, Y., Zhang, X., Gao, M., Zhang, Q., Li, X., et al. (2022) Salidroside Protects against Osteoporosis in Ovariectomized Rats by Inhibiting Oxidative Stress and Promoting Osteogenesis via Nrf2 Activation. Phytomedicine, 99, Article ID: 154020. [Google Scholar] [CrossRef] [PubMed]
[2] Forciea, M.A., McLean, R.M. and Qaseem, A. (2017) Treatment of Low Bone Density or Osteoporosis to Prevent Fractures in Men and Women: A Clinical Practice Guideline Update from the American College of Physicians. Annals of Internal Medicine, 167, Article No. 904. [Google Scholar] [CrossRef] [PubMed]
[3] Salari, N., Ghasemi, H., Mohammadi, L., Behzadi, M.h., Rabieenia, E., Shohaimi, S., et al. (2021) The Global Prevalence of Osteoporosis in the World: A Comprehensive Systematic Review and Meta-Analysis. Journal of Orthopaedic Surgery and Research, 16, Article No. 609. [Google Scholar] [CrossRef] [PubMed]
[4] Zeng, Q., Li, N., Wang, Q., Feng, J., Sun, D., Zhang, Q., et al. (2019) The Prevalence of Osteoporosis in China, a Nationwide, Multicenter DXA Survey. Journal of Bone and Mineral Research, 34, 1789-1797. [Google Scholar] [CrossRef] [PubMed]
[5] Si, L., Winzenberg, T.M., Jiang, Q., Chen, M. and Palmer, A.J. (2015) Projection of Osteoporosis-Related Fractures and Costs in China: 2010-2050. Osteoporosis International, 26, 1929-1937. [Google Scholar] [CrossRef] [PubMed]
[6] Zhivodernikov, I.V., Kirichenko, T.V., Markina, Y.V., Postnov, A.Y. and Markin, A.M. (2023) Molecular and Cellular Mechanisms of Osteoporosis. International Journal of Molecular Sciences, 24, Article No. 15772. [Google Scholar] [CrossRef] [PubMed]
[7] Deeks, E.D. (2018) Author Correction To: Denosumab: A Review in Postmenopausal Osteoporosis. Drugs & Aging, 35, Article No. 261. [Google Scholar] [CrossRef] [PubMed]
[8] Ilyas, Z. and Camacho, P.M. (2019) Rare Adverse Effects of Bisphosphonate Therapy. Current Opinion in Endocrinology, Diabetes & Obesity, 26, 335-338. [Google Scholar] [CrossRef] [PubMed]
[9] Deardorff, W.J., Cenzer, I., Nguyen, B. and Lee, S.J. (2022) Time to Benefit of Bisphosphonate Therapy for the Prevention of Fractures among Postmenopausal Women with Osteoporosis: A Meta-Analysis of Randomized Clinical Trials. JAMA Internal Medicine, 182, 33-41. [Google Scholar] [CrossRef] [PubMed]
[10] Yao, Z., Getting, S.J. and Locke, I.C. (2021) Regulation of TNF-Induced Osteoclast Differentiation. Cells, 11, Article No. 132. [Google Scholar] [CrossRef] [PubMed]
[11] Deng, T., Ding, W., Lu, X., Zhang, Q., Du, J., Wang, L., et al. (2024) Pharmacological and Mechanistic Aspects of Quercetin in Osteoporosis. Frontiers in Pharmacology, 15, Article ID: 1338951. [Google Scholar] [CrossRef] [PubMed]
[12] 尹春春. 早期神经毒性体外评价方法的建立及槟榔和虎杖的神经毒性评价[D]: [硕士学位论文]. 镇江: 江苏大学, 2017.
[13] Lin, Z., Xiong, Y., Hu, Y., Chen, L., Panayi, A.C., Xue, H., et al. (2021) Polydatin Ameliorates Osteoporosis via Suppression of the Mitogen-Activated Protein Kinase Signaling Pathway. Frontiers in Cell and Developmental Biology, 9, Article ID: 730362. [Google Scholar] [CrossRef] [PubMed]
[14] Chen, X., Shen, Y., He, M., Yang, F., Yang, P., Pang, F., et al. (2019) Polydatin Promotes the Osteogenic Differentiation of Human Bone Mesenchymal Stem Cells by Activating the Bmp2-Wnt/β-Catenin Signaling Pathway. Biomedicine & Pharmacotherapy, 112, Article ID: 108746. [Google Scholar] [CrossRef] [PubMed]
[15] 樊慧婷, 丁世兰, 林洪生. 中药虎杖的药理研究进展[J]. 中国中药杂志, 2013, 38(15): 2545-2548.
[16] Hsin, K., Ghosh, S. and Kitano, H. (2013) Combining Machine Learning Systems and Multiple Docking Simulation Packages to Improve Docking Prediction Reliability for Network Pharmacology. PLOS ONE, 8, e83922. [Google Scholar] [CrossRef] [PubMed]
[17] Li, H., Gong, Y., Wang, Y., Sang, W., Wang, C., Zhang, Y., et al. (2025) β-Sitosterol Modulates Osteogenic and Adipogenic Balance in BMSCs to Suppress Osteoporosis via Regulating mTOR-IMP1-Adipoq Axis. Phytomedicine, 138, Article ID: 156400. [Google Scholar] [CrossRef] [PubMed]
[18] Babu, S. and Jayaraman, S. (2020) An Update on β-Sitosterol: A Potential Herbal Nutraceutical for Diabetic Management. Biomedicine & Pharmacotherapy, 131, Article ID: 110702. [Google Scholar] [CrossRef] [PubMed]
[19] Guo, H., Chen, X., Li, J., Mo, G., Li, Y., Tang, Y., et al. (2025) β-Sitosterol Inhibits Osteoclast Activity and Reduces Ovariectomy-Induced Bone Loss by Regulating the cAMP and NF-κB Signaling Pathways. Cellular Signalling, 130, Article ID: 111672. [Google Scholar] [CrossRef] [PubMed]
[20] 王昊翔, 江树连, 袁杰, 等. 基于网络药理学和分子对接技术研究当归-川芎治疗骨折的作用机制[J]. 中医临床研究, 2025, 17(1): 15-22.
[21] Feng, R., Wang, Q., Yu, T., Hu, H., Wu, G., Duan, X., et al. (2024) Quercetin Ameliorates Bone Loss in OVX Rats by Modulating the Intestinal Flora-Scfas-Inflammatory Signaling Axis. International Immunopharmacology, 136, Article ID: 112341. [Google Scholar] [CrossRef] [PubMed]
[22] Vakili, S., Zal, F., Mostafavi‐pour, Z., Savardashtaki, A. and Koohpeyma, F. (2020) Quercetin and Vitamin E Alleviate Ovariectomy‐Induced Osteoporosis by Modulating Autophagy and Apoptosis in Rat Bone Cells. Journal of Cellular Physiology, 236, 3495-3509. [Google Scholar] [CrossRef] [PubMed]
[23] Jing, Z., Wang, C., Yang, Q., Wei, X., Jin, Y., Meng, Q., et al. (2018) Luteolin Attenuates Glucocorticoid‐Induced Osteoporosis by Regulating ERK/Lrp-5/GSK-3β Signaling Pathway in Vivo and in Vitro. Journal of Cellular Physiology, 234, 4472-4490. [Google Scholar] [CrossRef] [PubMed]
[24] Garlanda, C., Dinarello, C.A. and Mantovani, A. (2013) The Interleukin-1 Family: Back to the Future. Immunity, 39, 1003-1018. [Google Scholar] [CrossRef] [PubMed]
[25] Ruscitti, P., Cipriani, P., Carubbi, F., Liakouli, V., Zazzeroni, F., Di Benedetto, P., et al. (2015) The Role of Il‐1β in the Bone Loss during Rheumatic Diseases. Mediators of Inflammation, 2015, Article ID: 782382. [Google Scholar] [CrossRef] [PubMed]
[26] Ji, Y., Jiang, X., Li, W. and Ge, X. (2019) Impact of Interleukin-6 Gene Polymorphisms and Its Interaction with Obesity on Osteoporosis Risk in Chinese Postmenopausal Women. Environmental Health and Preventive Medicine, 24, Article No. 48. [Google Scholar] [CrossRef] [PubMed]
[27] Edwards, C.J. and Williams, E. (2010) The Role of Interleukin-6 in Rheumatoid Arthritis-Associated Osteoporosis. Osteoporosis International, 21, 1287-1293. [Google Scholar] [CrossRef] [PubMed]
[28] Shi, X., Jiang, J., Hong, R., Xu, F. and Dai, S. (2023) Circulating IGFBP-3 and Interleukin 6 as Predictors of Osteoporosis in Postmenopausal Women: A Cross-Sectional Study. Mediators of Inflammation, 2023, Article ID: 2613766. [Google Scholar] [CrossRef] [PubMed]
[29] Li, C., Ma, Z., Jian, L., Wang, X., Sun, L., Liu, X., et al. (2021) Iguratimod Inhibits Osteoclastogenesis by Modulating the RANKL and TNF-α Signaling Pathways. International Immunopharmacology, 90, Article ID: 107219. [Google Scholar] [CrossRef] [PubMed]
[30] Zhao, Z., Hou, X., Yin, X., Li, Y., Duan, R., Boyce, B.F., et al. (2015) TNF Induction of NF-κB RelB Enhances RANKL-Induced Osteoclastogenesis by Promoting Inflammatory Macrophage Differentiation but Also Limits It through Suppression of NFATc1 Expression. PLOS ONE, 10, e0135728. [Google Scholar] [CrossRef] [PubMed]
[31] Ghasemian, M., Rajabibazl, M., Sahebi, U., Sadeghi, S., Maleki, R., Hashemnia, V., et al. (2022) Long Non-Coding RNA MIR4435-2HG: A Key Molecule in Progression of Cancer and Non-Cancerous Disorders. Cancer Cell International, 22, Article No. 215. [Google Scholar] [CrossRef] [PubMed]
[32] Yang, Y., Lu, L., Wang, J., Ma, S., Xu, B., Lin, R., et al. (2023) Tubson-2 Decoction Ameliorates Rheumatoid Arthritis Complicated with Osteoporosis in CIA Rats Involving Isochlorogenic Acid a Regulating IL-17/MAPK Pathway. Phytomedicine, 116, Article ID: 154875. [Google Scholar] [CrossRef] [PubMed]
[33] Chen, W., Wu, P., Yu, F., Luo, G., Qing, L. and Tang, J. (2022) HIF-1α Regulates Bone Homeostasis and Angiogenesis, Participating in the Occurrence of Bone Metabolic Diseases. Cells, 11, Article No. 3552. [Google Scholar] [CrossRef] [PubMed]